Clinical trial · no report yet · Phase not applicable
SENOMAC-ULTRA
Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer
- NCT06869629 ↗
- Recruiting
- Karolinska Institutet
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 2 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- SENOMAC-ULTRA: A Prospective Randomised Trial on the Omission of Axillary Lymph Node Dissection in Ultrasound-detectable Axillary Metastases in Primary Breast Cancer Treated by Upfront Surgery
- Phase
- Phase not applicable
- Status
- Recruiting
- Conditions
- Breast Carcinoma; Breast Cancer; Breast Surgery
- Interventions
- Targeted axillary dissection; Axillary lymph node dissection
- Arms
- Axillary lymph node dissection · Active comparator
- Targeted axillary dissection · Experimental
- Enrollment
- 1,380 (estimated)
- Primary outcomes
- Recurrence-free survival
- Sponsor
- Karolinska Institutet
- Start
- May 13, 2026
- Primary completion
- Dec 31, 2031 (estimated)
- Results posted
- No
- Registry record
- NCT06869629 · updated Aug 17, 2026
Publications
linked from the registry- de Boniface J, Meretoja T, Ryden L, Sund M, Karlsson P, Huang CS, Kim HJ, Ryu JM, Nash S, Offersen B, Dahl Nissen H, Wieslander E, Maggi N, Swedin L, Kuo SH, Tramm T, Dembrower K, Terata K, Nishibuchi I, Luna Tomas MA, Ciervide R, Lowery A, Skjerven HK, Ejlertsen B, Valachis A, Szulkin R, Spanic T, Shien T, Filtenborg Tvedskov T, Alkner S. Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial. BJS Open. 2026 Jul 3;10(4):zrag083. doi: 10.1093/bjsopen/zrag083. PubMed 42551036